.OS Therapies will definitely specify on the NYSE American inventory substitution today through a $6...
.ALX Oncology's phase 2 gastric cancer action rate has weakened. After seeing its CD47 blocker quick...
.An Additional of Ionis Pharmaceuticals' key midphase readouts has actually fallen short of expectat...
.While Biogen's pharma peers are looking for late-stage resources with little risk, chief executive ...
.Instil Biography has been actually a biotech looking for a pipe after it scrapped its own lead prop...
.Biogen has returned civil liberties to a very early Alzheimer's illness system to Denali Therapies,...
.Invite to today's Chutes & Ladders, our summary of significant management hirings, firings and a...
.Tip's effort to address a rare hereditary condition has hit another setback. The biotech tossed two...
.Vir Biotechnology's second-quarter profits report wasn't short of big news. The firm welcomed a tri...
.Galapagos has stopped registration in a trial of a BCMA-directed CAR-T cell treatment, pushing the ...